Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results

MARLBOROUGH, Mass., April 1, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast a conference call on Tuesday, April 28, 2015 at 8 a.m. ET to review financial results and business highlights for the first quarter 2015. The company will issue a news release announcing first quarter financial results prior to the conference call.

The call will be hosted by Mike Mahoney, president and chief executive officer, and Dan Brennan, executive vice president and chief financial officer.

A live webcast of the conference call will be available via the Boston Scientific website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection. A replay of the webcast will be accessible on the Investor Relations page approximately one hour following the completion of the conference call and available for approximately one year.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

 

Media:

Investors:

Kelly Leadem

Susie Lisa, CFA

508-683-5543 (office)

508- 683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation      

Boston Scientific Corporation

kelly.leadem@bsci.com

investor_relations@bsci.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-webcast-conference-call-on-first-quarter-2015-financial-results-300058722.html

SOURCE Boston Scientific Corporation

Top